You have 9 free searches left this month | for more free features.

intravenous

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MRI and Computational Simulation Cardiology Study

Enrolling by invitation
  • Congenital Heart Disease
  • Pulmonary Hypertension
  • Magnetic Resonance Imaging
  • Palo Alto, California
    Lucile Packard Children's Hospital at Stanford
Sep 15, 2021

Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type II Trial in Worldwide (Apitegromab)

Not yet recruiting
  • Spinal Muscular Atrophy
  • +9 more
  • Phoenix, Arizona
  • +26 more
Nov 15, 2022

COVID-19 Trial in France (hospitalized children with Covid19)

Recruiting
  • COVID-19
  • hospitalized children with Covid19
  • Saint Denis, La Réunion, France
  • +75 more
Nov 21, 2022

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Diabetic Foot Osteomyelitis Trial (Stimulan-VG, Systemic Antibiotics)

Not yet recruiting
  • Diabetic Foot Osteomyelitis
  • (no location specified)
Sep 15, 2022

Neuroimaging Ancillary Study

Not yet recruiting
  • Iron Deficiency Anemia
  • +5 more
  • Ferric carboxymaltose
  • +2 more
  • Belgaum, Karnataka, India
    Jawaharlal Nehru Medical College
Sep 14, 2022

Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC(FOLFOX)
  • +5 more
  • (no location specified)
Aug 16, 2022

Prostate Cancer Trial in Seoul (Ga-68 PSMA-11 PET/CT imaging)

Active, not recruiting
  • Prostate Cancer
  • Ga-68 PSMA-11 PET/CT imaging
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Sep 27, 2021

Ischemic Stroke Trial in Dijon (prise de sang, quality of life questionnaire)

Completed
  • Ischemic Stroke
  • prise de sang
  • quality of life questionnaire
  • Dijon, France
    CHU Dijon Bourgogne
Nov 24, 2021

Outcomes Study (FIGARO)

Completed
  • Primary Immunodeficiency
  • Secondary Immune Deficiency
  • HyQvia
  • Paris, France
  • +3 more
Mar 18, 2022

Parkinson's Disease Trial in Puerto Rico, United States (ABBV-0805, Placebo ABBV-0805)

Withdrawn
  • Parkinson's Disease
  • Gainesville, Florida
  • +5 more
Dec 13, 2021

Biliary Tract Carcinoma Trial in China (Pembrolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Biliary Tract Carcinoma
  • Pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +21 more
Aug 16, 2022

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Niraparib, Dostarlimab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Oct 18, 2021

d to Treat Drug Sensitive Tuberculosis in Breastfeeding

Recruiting
  • Tuberculosis Active
  • +2 more
  • First line tuberculosis treatment
  • Kampala, Uganda
    Infectious Diseases Institute
Apr 22, 2023

Molecular Culture for the Diagnosis of Pediatric Sepsis

Not yet recruiting
  • Sepsis
  • +5 more
  • Molecular Culture
  • (no location specified)
Aug 29, 2023

Lumbar Disc Herniation Trial in Bani Suwayf (transforaminal epidural injection., micro RNA-155 serum level)

Recruiting
  • Lumbar Disc Herniation
  • transforaminal epidural injection.
  • micro RNA-155 serum level
  • Banī Suwayf, Beni-Suef, Egypt
    Mona Hussein
Nov 19, 2022

Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028, Salvage Chemotherapy)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Chengdu, Sichuan, China
    West China hospital of Sichuan University
Nov 1, 2021

Acute Ischemic Stroke Trial in Beijing (Shuxinin injection, Basic treatment, Placebo)

Recruiting
  • Acute Ischemic Stroke
  • Shuxinin injection
  • +2 more
  • Beijing, China
    Peking University Third Hospital
Jul 4, 2021

Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic

Recruiting
  • Pancreas Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Gemcitabine 1000 mg
  • +2 more
  • Loma Linda, California
    Loma Linda University Health
Jun 14, 2022

Solid Tumor, Breast Cancer, Cancer of Head and Neck Trial in Worldwide (RO6874281, Trastuzumab, Cetuximab)

Completed
  • Solid Tumor
  • +2 more
  • Tucson, Arizona
  • +25 more
Nov 21, 2022

Hypotension on Induction Trial (Remimazolam bolus, Remimazolam continuous)

Not yet recruiting
  • Hypotension on Induction
  • Remimazolam bolus
  • Remimazolam continuous
  • (no location specified)
Sep 12, 2022

Acute Anterior or Posterior Cerebral Artery Occlusion

Completed
  • Ischemic Stroke
  • Thrombi
    • Paris, Ile-de-France, France
      Hôpital Fondation Adolphe de Rothschild
    Dec 9, 2022

    Idiopathic Pulmonary Fibrosis Trial in Worldwide (CSL312, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Birmingham, Alabama
    • +20 more
    Aug 12, 2022

    Triple Negative Breast Cancer, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma Trial in United Kingdom

    Recruiting
    • Triple Negative Breast Cancer
    • +3 more
    • Modi-1/Modi-1v
    • +2 more
    • Brighton, Default, United Kingdom
    • +13 more
    Nov 18, 2022